MCCC1 Gene

MCCC1 Gene

Introduction

MCCC1 (Methylcrotonoyl-CoA Carboxylase 1) encodes the alpha subunit of methylcrotonoyl-CoA carboxylase (MCC), a biotin-dependent mitochondrial enzyme that plays a critical role in the catabolism of the branched-chain amino acid leucine[@baumgartner2001]. Located in the mitochondrial matrix, MCC catalyzes the carboxylation of 3-methylcrotonyl-CoA to 3-methylglutaconyl-CoA, an essential step in the leucine degradation pathway that generates acetyl-CoA and acetoacetate for energy production[@gallagher2019].

This gene has garnered significant attention in the context of neurodegenerative diseases due to its dual role in amino acid metabolism and mitochondrial function. MCCC1 mutations cause 3-methylcrotonyl-CoA carboxylase deficiency (MCCD), a rare autosomal recessive metabolic disorder that can present with severe neurological manifestations including developmental delay, seizures, and progressive encephalopathy[@leonard2000]. Furthermore, emerging research suggests that alterations in MCCC1 expression and activity may contribute to the pathogenesis of Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions through effects on mitochondrial energy metabolism and branched-chain amino acid (BCAA) homeostasis[@mullen2012][@wang2018].

<div class="infobox infobox-gene">

MCCC1 Gene

Introduction

MCCC1 (Methylcrotonoyl-CoA Carboxylase 1) encodes the alpha subunit of methylcrotonoyl-CoA carboxylase (MCC), a biotin-dependent mitochondrial enzyme that plays a critical role in the catabolism of the branched-chain amino acid leucine[@baumgartner2001]. Located in the mitochondrial matrix, MCC catalyzes the carboxylation of 3-methylcrotonyl-CoA to 3-methylglutaconyl-CoA, an essential step in the leucine degradation pathway that generates acetyl-CoA and acetoacetate for energy production[@gallagher2019].

This gene has garnered significant attention in the context of neurodegenerative diseases due to its dual role in amino acid metabolism and mitochondrial function. MCCC1 mutations cause 3-methylcrotonyl-CoA carboxylase deficiency (MCCD), a rare autosomal recessive metabolic disorder that can present with severe neurological manifestations including developmental delay, seizures, and progressive encephalopathy[@leonard2000]. Furthermore, emerging research suggests that alterations in MCCC1 expression and activity may contribute to the pathogenesis of Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions through effects on mitochondrial energy metabolism and branched-chain amino acid (BCAA) homeostasis[@mullen2012][@wang2018].

<div class="infobox infobox-gene">

| Property | Value |
|----------|-------|
| Gene Symbol | MCCC1 |
| Full Name | Methylcrotonoyl-CoA Carboxylase 1 |
| Alternative Names | MCC alpha, MCCA |
| Chromosomal Location | 3q27.1 |
| NCBI Gene ID | 56955 |
| OMIM ID | 210200 |
| Ensembl ID | ENSG00000071889 |
| UniProt ID | Q9P2R3 |
| Protein Length | 726 amino acids |
| Molecular Weight | ~82 kDa |
| Associated Diseases | 3-Methylcrotonyl-CoA Carboxylase Deficiency, Parkinson's Disease, Alzheimer's Disease |

</div>

Gene Structure and Evolution

Genomic Organization

The MCCC1 gene is located on chromosome 3q27.1 and consists of 26 exons spanning approximately 30 kb of genomic DNA. The gene encodes a precursor protein that is imported into mitochondria after synthesis in the cytosol.

Evolutionary Conservation

MCCC1 is evolutionarily conserved across eukaryotes:

• Vertebrates: Highly conserved protein sequences
• Drosophila: Functional ortholog identified
• Yeast: MAS1 gene (mitochondrial MCC)
• Plants: Functional homologs in Arabidopsis

Related Genes

• MCCC2: Encodes the beta subunit of methylcrotonoyl-CoA carboxylase
• PCCB: Propionyl-CoA carboxylase beta subunit
• PC: Pyruvate carboxylase (biotin-dependent)
• PAH: Phenylalanine hydroxylase

Protein Structure and Function

Subunit Composition

Methylcrotonoyl-CoA carboxylase is a heterododecameric complex consisting of[@baumgartner2001]:

• 6 alpha subunits (MCCC1): Contain the biotin carboxylase and biotin-binding domains
• 6 beta subunits (MCCC2): Contain the carboxyltransferase domain

Catalytic Mechanism

MCC catalyzes an ATP-dependent carboxylation reaction:

Reaction steps:

Biotin Dependence

MCC requires biotin as an essential cofactor[@chen2022]:

• Biotin serves as a CO₂ carrier
• Holocarboxylase synthetase attaches biotin to MCCC1
• Biotin deficiency can impair MCC activity

Biological Functions

Leucine Catabolism

MCCC1 is essential for leucine degradation[@yang2021]:

Leucine Metabolism Pathway

Leucine → α-Ketoisocaproate → Isovaleryl-CoA → 3-Methylcrotonyl-CoA
↓ (MCC)
3-Methylglutaconyl-CoA → 3-Hydroxy-3-methylglutaryl-CoA
↓
Acetoacetate + Acetyl-CoA → Ketogenesis / TCA Cycle

Mitochondrial Energy Metabolism

MCC contributes to mitochondrial function[@garcia2021]:

• ATP generation: Through TCA cycle coupling
• Ketone body production: Important for brain energy during fasting
• Metabolic flexibility: Links amino acid catabolism to energy production

Amino Acid Homeostasis

Proper MCCC1 function maintains[@huang2019]:

• Branched-chain amino acid balance
• Glutamate metabolism
• Nitrogen disposal

Expression Pattern

Tissue Distribution

MCCC1 is expressed in various tissues with highest levels in:

| Tissue | Expression Level | Metabolic Context |
|--------|-----------------|------------------|
| Liver | Very high | Primary leucine catabolism |
| Kidney | High | Gluconeogenesis |
| Heart | High | Energy metabolism |
| Skeletal muscle | High | BCAA catabolism |
| Brain | Moderate | Neural metabolism |
| Lung | Moderate | General metabolism |

Brain Expression

Within the brain, MCCC1 is expressed in[@chen2020]:

• Neurons: Particularly in regions with high metabolic demand
• Astrocytes: Supporting neuronal metabolism
• Oligodendrocytes: Myelin production support
• Endothelial cells: Blood-brain barrier function

Regulation

MCCC1 expression is regulated by:

• Dietary protein intake: Increased by high leucine diets
• Fasting: Upregulated to support gluconeogenesis
• Hormones: Glucagon and cortisol upregulate expression
• Developmental stage: Higher expression in developing brain

Role in Alzheimer's Disease

Metabolic Alterations

MCCC1 dysfunction may contribute to AD pathogenesis through[@huang2019]:

• Impaired glucose metabolism: Reduced ketone body production
• Energy deficits: Compromised ATP generation in neurons
• BCAA accumulation: Altered amino acid homeostasis

Molecular Connections

Therapeutic Implications

Targeting MCCC1 in AD:

• Ketogenic diets: Bypass metabolic block
• Ketone supplementation: Provide alternative energy
• Gene expression modulation: Upregulate MCCC1

Role in Parkinson's Disease

Mitochondrial Connections

MCCC1 alterations in PD include[@chen2020][@liu2022]:

• Expression changes: Altered MCCC1 levels in PD brain
• Activity deficits: Reduced MCC activity in substantia nigra
• Metabolic consequences: Impaired energy production

Leucine Toxicity

Paradoxically, while leucine is essential:

• Excess leucine: Can impair dopaminergic neuron function
• MCCC1 insufficiency: May lead to toxic metabolite accumulation
• mTOR dysregulation: Leucine affects mTOR signaling

Clinical Observations

• PD patients: Altered plasma BCAA profiles
• Levodopa response: BCAA interactions with treatment
• Dietary implications: Protein timing in PD

3-Methylcrotonyl-CoA Carboxylase Deficiency

Clinical Presentation

MCCD (OMIM #210200) is an autosomal recessive disorder[@gallagher2019]:

| Feature | Typical Presentation |
|---------|---------------------|
| Onset | Infancy to early childhood |
| Developmental delay | Variable severity |
| Seizures | Common |
| Cardiomyopathy | Can occur |
| Hypotonia | Profound weakness |
| Metabolic crisis | Triggered by illness/fasting |

Metabolic Derangements

• Elevated 3-hydroxyisovaleric acid: Diagnostic urinary marker
• 3-Methylcrotonylglycine: Elevated in urine
• Carnitine depletion: Secondary carnitine deficiency
• Hypoglycemia: During metabolic crises

Treatment Approaches

• Dietary restriction: Limit leucine intake
• Carnitine supplementation: Correct secondary deficiency
• Glycine supplementation: Enhance excretion
• Emergency protocol: For metabolic crises

Therapeutic Implications

Neurodegeneration

MCCC1-based therapeutic strategies[@zhang2023]:

| Approach | Mechanism | Status |
|----------|-----------|--------|
| Ketogenic diet | Bypass metabolic block | Clinical use |
| Ketone esters | Provide alternative fuel | Research |
| Gene therapy | Restore MCCC1 function | Preclinical |
| Biotin supplementation | Cofactor support | Adjunct therapy |

Precision Medicine

• Genotyping: Identify MCCC1 variants
• Metabolomic profiling: Monitor BCAA levels
• Personalized approaches: Tailor dietary interventions

Interaction Network

Metabolic Pathway Partners

MCCC1 interacts with multiple metabolic enzymes:

| Enzyme | Pathway | Relationship |
|--------|---------|-------------|
| BCKDH | Leucine catabolism | Upstream step |
| HMGCS2 | Ketogenesis | Downstream step |
| ACAT1 | Ketone body utilization | Downstream |
| CS | TCA cycle | Provides acetyl-CoA |
| IDH3 | TCA cycle | Provides α-KG |

Regulatory Proteins

• PGC-1α: Mitochondrial biogenesis regulator
• SIRT1: Metabolic sensor
• AMPK: Energy sensor
• mTOR: Nutrient signaling

Biomarker Potential

Blood-Based Biomarkers

MCCC1-related metabolites as disease biomarkers:

| Metabolite | Disease | Direction | Utility |
|------------|---------|-----------|----------|
| 3-Hydroxyisovaleric acid | MCCD | Elevated | Diagnostic |
| Leucine | AD/PD | Altered | Research |
| Ketone bodies | AD/PD | Reduced | Prognostic |
| 3-Methylcrotonylglycine | MCCD | Elevated | Diagnostic |

CSF Biomarkers

• BCAA levels: Altered in neurodegeneration
• Ketone body ratios: Energy status indicator
• MCC activity: Enzymatic function

Animal Models

Knockout Models

MCCC1 knockout mice:

• Lethal: Homozygous knockout is embryonic lethal
• Heterozygotes: Show metabolic phenotypes
• Tissue-specific: Conditional knockouts studied

Disease Models

• AD models: MCCC1 expression changes
• PD models: Metabolomic alterations
• Aging models: Activity decline

Comparative Analysis

Species Differences

| Species | MCCC1 Features | Notes |
|---------|---------------|-------|
| Human | Full-length enzyme | 726 aa |
| Mouse | Highly conserved | 725 aa |
| Zebrafish | Functional ortholog | Brain expression |
| Drosophila | Homolog identified | Metabolic function |
| Yeast | MAS1 protein | Mitochondrial |

Isoform Diversity

Alternative splicing generates multiple MCCC1 isoforms:

• Canonical isoform: Full-length protein
• Alternative transcripts: Tissue-specific expression
• Regulatory variants: Differential regulation

Future Directions

Research Priorities

Emerging Questions

• Role of MCCC1 in specific neuronal subtypes
• Sex differences in MCCC1 function
• Interactions with other metabolic genes
• Environmental modifiers of MCCC1 effects

Clinical Management

Diagnostic Approaches

• Newborn screening: Elevated C5-OH on tandem mass spec
• Enzyme assay: Lymphocyte MCC activity
• Genetic testing: MCCC1 sequencing
• Metabolomics: Urine organic acid analysis

Long-Term Management

• Dietary therapy: Leucine restriction
• Monitoring: Regular metabolic assessments
• Complications: Cardiac and neurological monitoring
• Supportive care: Multidisciplinary approach

Summary

MCCC1 represents a critical intersection between amino acid metabolism, mitochondrial function, and neurodegenerative disease. While primarily known for its role in leucine catabolism and the rare metabolic disorder MCC deficiency, emerging evidence suggests that alterations in MCCC1 function may contribute to the pathogenesis of more common neurodegenerative conditions including Alzheimer's and Parkinson's diseases. The enzyme's position at the crossroads of branched-chain amino acid metabolism, ketogenesis, and mitochondrial energy production makes it an important therapeutic target. Understanding the precise molecular mechanisms by which MCCC1 dysfunction contributes to neurodegeneration—and developing effective interventions—remains an important area of ongoing research.

See Also

• [MCCC2 Gene](/genes/mccc2)
• [Leucine Metabolism](/mechanisms/leucine-metabolism)
• [Branched-Chain Amino Acids](/mechanisms/branched-chain-amino-acid-metabolism)
• [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [3-Methylcrotonyl-CoA Carboxylase Deficiency](/diseases/3-mcc-deficiency)

External Links

• [NCBI Gene: MCCC1](https://www.ncbi.nlm.nih.gov/gene/56955)
• [UniProt: Q9P2R3](https://www.uniprot.org/uniprot/Q9P2R3)
• [OMIM: 210200](https://www.omim.org/entry/210200)
• [Ensembl: MCCC1](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000071889)

References